CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
1-Year Return
31.81%
This Quarter Return
+18.11%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$514M
AUM Growth
+$169M
(+49%)
Cap. Flow
+$116M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$6.88M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.46M |
| 3 |
Gilead Sciences
GILD
|
$6.38M |
| 4 |
Amgen
AMGN
|
$6.24M |
| 5 |
Adobe
ADBE
|
$5.19M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$5.18M |
| 2 |
Analog Devices
ADI
|
$3.75M |
| 3 |
Amazon
AMZN
|
$3.48M |
| 4 |
lululemon athletica
LULU
|
$3.4M |
| 5 |
iQIYI
IQ
|
$1.91M |
Sector Composition
| 1 | Technology | 34.39% |
| 2 | Healthcare | 30.05% |
| 3 | Consumer Discretionary | 17.55% |
| 4 | Communication Services | 6.11% |
| 5 | Consumer Staples | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Yum! Brands
YUM
$41.1B
| $299K | 0.06% |
2,285
| – | – |
|
|
VRNA
177
Verona Pharma
VRNA
$9.19B
| $296K | 0.06% |
14,878
-40,806
| -73% | -$811K |
|
|
CTLT
178
DELISTED
CATALENT, INC.
CTLT
| $283K | 0.06% |
6,301
-38,319
| -86% | -$1.72M |
|
179
Honeywell
HON
$136B
| $275K | 0.05% |
1,312
-1,162
| -47% | -$244K |
|
180
Crinetics Pharmaceuticals
CRNX
$3.31B
| $275K | 0.05% |
7,721
+6,318
| +450% | +$225K |
|
181
Applied Materials
AMAT
$129B
| $268K | 0.05% |
1,652
-1,465
| -47% | -$237K |
|
182
Immunocore
IMCR
$1.85B
| $266K | 0.05% |
3,900
+3,064
| +367% | +$209K |
|
183
IDEAYA Biosciences
IDYA
$2.05B
| $265K | 0.05% |
7,453
+5,979
| +406% | +$213K |
|
|
SWTX
184
DELISTED
SpringWorks Therapeutics
SWTX
| $264K | 0.05% |
7,237
+5,625
| +349% | +$205K |
|
185
Beam Therapeutics
BEAM
$2.02B
| $263K | 0.05% |
9,667
+7,395
| +325% | +$201K |
|
186
Arvinas
ARVN
$583M
| $262K | 0.05% |
6,370
+4,996
| +364% | +$206K |
|
187
Full Truck Alliance
YMM
$13.8B
| $260K | 0.05% |
37,130
-125,700
| -77% | -$881K |
|
188
Twist Bioscience
TWST
$1.58B
| $246K | 0.05% |
6,674
+5,204
| +354% | +$192K |
|
189
Iovance Biotherapeutics
IOVA
$861M
| $241K | 0.05% |
29,602
+23,246
| +366% | +$189K |
|
190
PTC Therapeutics
PTCT
$4.52B
| $241K | 0.05% |
8,727
+6,786
| +350% | +$187K |
|
191
Recursion Pharmaceuticals
RXRX
$2.02B
| $238K | 0.05% |
24,091
+18,854
| +360% | +$186K |
|
192
VF Corp
VFC
$6.08B
| $234K | 0.05% |
+12,460
| New | +$234K |
|
193
Veracyte
VCYT
$2.55B
| $232K | 0.05% |
8,448
+6,586
| +354% | +$181K |
|
194
Schrodinger
SDGR
$1.43B
| $229K | 0.04% |
6,410
-16,092
| -72% | -$576K |
|
195
Prothena Corp
PRTA
$457M
| $225K | 0.04% |
6,203
+4,828
| +351% | +$175K |
|
196
ChargePoint
CHPT
$253M
| $222K | 0.04% |
4,750
| – | – |
|
197
Harmony Biosciences
HRMY
$2.06B
| $219K | 0.04% |
6,777
+5,244
| +342% | +$169K |
|
198
Levi Strauss
LEVI
$8.76B
| $215K | 0.04% |
+12,970
| New | +$215K |
|
199
Summit Therapeutics
SMMT
$14.4B
| $212K | 0.04% |
81,071
+63,168
| +353% | +$165K |
|
200
Dynavax Technologies
DVAX
$1.14B
| $209K | 0.04% |
+14,956
| New | +$209K |
|